Yersinia pestis undergoes an obligate flea-rodent-flea enzootic life cycle. The rapidly fatal properties of Y. pestis are responsible for the organism's sustained survival in natural plague foci. Lipopolysaccharide (LPS) plays several roles in Y. pestis pathogenesis, prominent among them being resistance to host immune effectors and induction of a septic-shock state during the terminal phases of infection. LPS is acylated with 4-6 fatty acids, the number varying with growth temperature and affecting the molecule's toxic properties. Y. pestis mutants were constructed with a deletion insertion in the lpxM gene in both virulent and attenuated strains, preventing the organisms from synthesizing the most toxic hexa-acylated lipid A molecule when grown at 25 6C. The virulence and/or protective potency of pathogenic and attenuated Y. pestis DlpxM mutants were then examined in a mouse model. The DlpxM mutation in a virulent strain led to no change in the LD 50 value compared to that of the parental strain, while the DlpxM mutation in attenuated strains led to a modest 2.5-16-fold reduction in virulence. LPS preparations containing fully hexa-acylated lipid A were ten times more toxic in actinomycin D-treated mice then preparations lacking this lipid A isoform, although this was not significant (P.0.05). The DlpxM mutation in vaccine strain EV caused a significant increase in its protective potency. These studies suggest there is little impact from lipid A modifications on the virulence of Y. pestis strains but there are potential improvements in the protective properties in attenuated vaccine strains.
INTRODUCTION
Yersinia pestis survives within an enzootic cycle involving infection of susceptible rodent populations and transmission via flea vectors (Anisimov, 1999a (Anisimov, , 2002a Brubaker, 1991; Hinnebusch, 2003 Hinnebusch, , 2004 Lorange et al., 2005; Perry, 2003; Perry & Fetherston, 1997) . To maintain this cycle, Y. pestis must first cause a sustained and high-level bacteraemia in rodents that is sufficient to transfer the microbe to fleas following a blood meal (Anisimov, 1999a (Anisimov, , 2002a Brubaker, 1991; Feodorova & Golova, 2005; Hinnebusch, 2004; Lorange et al., 2005; Perry & Fetherston, 1997) . Next, Y. pestis must colonize the flea's alimentary canal producing a bacterial biofilm that blocks the proventriculus, the organ that connects the flea's oesophagus to its midgut. This blockage prevents the flea from taking a blood meal and forces it to bite a warm-blooded host repeatedly in a futile attempt to feed. At this stage, regurgitated bacteria enter the skin tissues at the site of the flea bite (Anisimov, 1999a (Anisimov, , 2002a Brubaker, 1991; Hinnebusch, 2003 Hinnebusch, , 2004 Lorange et al., 2005; Perry, 2003; Perry & Fetherston, 1997) . The bacteraemia caused by Y. pestis results from its impressive ability to overcome mammalian host defences and overwhelm hosts with massive growth (Anisimov, 2002a, b; Brubaker, 1991; Feodorova & Golova, 2005; Hinnebusch, 2004; Lorange et al., 2005; Perry & Fetherston, 1997) . Usually the bacteraemic phase evolves into lethal septic shock and the host's death forcing fleas to depart to feed on a new rodent, which subsequently becomes infected (Anisimov, 1999a (Anisimov, , 2002a Brubaker, 1991; Butler, 1989) .
The triggering event of septic shock caused by Gramnegative bacteria is most likely the release of lipopolysaccharide (LPS). Lipid A, the toxic portion of the LPS molecule, causes the release of numerous host proinflammatory cytokines, and activates the complement cascade and the coagulation cascade. Recent studies suggest that Toll-like receptors, inflammatory cytokines, eicosanoids, free radicals, macrophage migration inhibitory factor, signal protein kinases and transcription factors all play an important part in the pathobiology of Gram-negativemediated septic shock (Das, 2000; van Amersfoort et al., 2003) . Y. pestis LPS has no repeating O-antigen-like polysaccharide but is composed of lipid A and a temperaturedependent variable oligosaccharide analogous to the inner and outer core of enterobacterial LPS (Gremyakova et al., 2003; Hitchen et al., 2002; Kawahara et al., 2002; Knirel et al., 2005a, b; Prior et al., 2001; Rebeil et al., 2004; Vinogradov et al., 2002) . As it was shown for prototypic lipid A from Escherichia coli, its characteristic structural features, especially its two acyloxyacyl moieties and its two phosphate groups, are needed to trigger the endotoxin response in mammalian cells (Alexander & Rietschel, 2001; Rietschel et al., 1994) . Recently it was shown that in Y. pestis the increase from flea temperature (21-28 u C) to the host temperature (37 u C) caused a reduction of the immunostimulatory/endotoxic activity of LPS (Kawahara et al., 2002; Rebeil et al., 2004; Tynianova et al., 2003) and a subsequent decrease of the degree of acylation of the lipid A from six to four fatty-lipid residues (Kawahara et al., 2002; Knirel et al., 2005a; Rebeil et al., 2004) . lpxM (alternatively msbB or waaN) (Reeves et al., 1996) is involved in the biosynthesis of lipid A. LpxM is a latefunctioning acyltransferase for myristate (C 14 ), which functions optimally after laurate (C 12 ) incorporation by LpxL (alternatively HtrB or WaaM) (Reeves et al., 1996) onto the E. coli KDO 2 -lipid IV A (2-keto-3-deoxyoctulosonic acid) structure Raetz & Whitfield, 2002) . Both LpxL and LpxM are the KDO-dependent acyltransferases responsible for the addition of a secondary acyl substitution on the lipid A portion of LPS (Brozek & Raetz, 1990; Clementz et al., 1997; Nichols et al., 1997; Raetz & Whitfield, 2002; Sunshine et al., 1997) . LPS isolated from DlpxM knockout mutants contains penta-acylated lipid A and E. coli DlpxM viable cells or purified LPS from this mutant had a 1000-10 000-fold reduction in the ability to stimulate E-selectin production by human endothelial cells and TNF-a production by adherent monocytes when compared with parent bacteria harbouring hexa-acylated lipid A (Somerville et al., 1996) . Recently it was shown that the Y. pestis lpxM (Dentovskaya et al., 2006; Rebeil et al., 2006) and lpxP (Rebeil et al., 2006) homologues encode the acyltransferases that add C 12 and C 16:1 groups, respectively, to lipid IV A to generate the hexa-acylated form, and that their expression is upregulated at 21 u C in vitro and in the flea midgut (Rebeil et al., 2006) .
Recently it was shown that although LPSs from DlpxM mutants had decreased endotoxic activity, they were still as potent adjuvants of the immune response as hexa-acylated molecules from the parent strains (Steeghs et al., 1999; van der Ley et al., 2001) due to the equal ability of the hexa-and penta-acylated forms to upregulate surface molecule expression on dendritic cells and stimulate T-cells (Kalupahana et al., 2003) . Thus, a penta-acylated LPS isolated from a DlpxL1 mutant of Neisseria meningitidis had decreased endotoxic activity but was still a potent adjuvant for immune responses (van der Ley et al., 2001) . These findings suggest that a Y. pestis DlpxM mutant also may be less virulent but may be useful for the development of new vaccines.
In this study, we investigated the effects of variations in the lipid A structure on the endotoxic activity of the LPS and on the pathogenicity of Y. pestis strains that differ in their initial virulence potential. To perform these investigations, we created DlpxM mutants in wild-type strain 231 as well as in attenuated strains, including the Russian vaccine strain, EV, line NIIEG. We also investigated the effect of a DlpxM mutation on the vaccine properties of strain EV. This mutation resulted in an inability to synthesize the hexa-acyl lipid A (LA hexa ) structure found in the parental strains when organisms are grown at 25 u C. Overall, we found a tenfold increase in the LD 50 of the LPS from the DlpxM mutant, but this was not significant at P . 0.05. Inability of the virulent Y. pestis 231 DlpxM mutant to produce a hexa-acylated LPS did not change its ability to cause a lethal infection, while in the attenuated strains there was a modest reduction in virulence. Of note, in the vaccine strain, there was improved protective efficacy and decreased reactogenicity following immunization with the DlpxM mutant.
METHODS
Bacterial strains, plasmids and primers. The characteristics of the Y. pestis and E. coli strains used in this study are given in Table 1 . Y. pestis strains were obtained from the Russian Anti-Plague Research Institute 'Microbe' (Russia) and were used in our previous studies as representatives of different biovars (Anisimov et al., 2005; Knirel et al., 2005a, b) . Bacterial cultures were started from lyophilized stocks. For LPS isolation and structural analysis, to guarantee the safety of the investigators, Y. pestis strain 231 was cured of the pCD virulence plasmid by selection at 37 uC on magnesium oxalate agar plates (Higuchi & Smith, 1961) . The variant was completely avirulent in mice at 10 8 organisms by the parenteral route. None of the absent plasmids (pFra, pCD, pPst) or missing parts of the genome (Dpgm) of the mutant strains contained genes for LPS biogenesis, and did not exert influence on LPS structure when compared with the 'wild-type' in any of the strains (Hitchen et al., 2002; Kawahara et al., 2002; Knirel et al., 2005a; Rebeil et al., 2004) except for specially generated mutants (DlpxM mutants in this study). Plasmids and primers used are listed in Tables 2 and 3 .
Medium and culture conditions. E. coli strains were routinely grown on Luria-Bertani (LB) agar or in LB broth (Miller, 1972) , pH 6.9-7.1. pH and pO 2 control was used with the specified pO 2 value .10 %. The Y. pestis cellular biomasses were harvested by centrifugation, after 48 h of incubation, and then freezedried. Growth media were supplemented, as needed, with ampicillin (50 mg ml Mutagenesis. A region 1529 bp 59 (designated left shoulder) and a region 1500 bp 39 (designated right shoulder) of the lpxM gene, including the first 180 nucleotides and the last 194 nucleotides, respectively (Table 3) , were amplified by PCR with the use of a DNA template obtained from strain 231. The primers for the left shoulder, msb5S1.5 and msb3X, contained SacI and XbaI restriction sites, respectively. The primers for the right shoulder, msb5H and msb3S1.5, contained HindIII and SacI restriction sites, respectively (Table 3) . To create the DlpxM mutants, the amplified left and right shoulders of the Y. pestis lpxM gene were gel purified, and cloned into the pBluescript SK (2) vector (Stratagene) within appropriate restriction sites. The resulting recombinant plasmids, pBsLS and pBsRS, respectively, were used to transform E. coli JM83 by electroporation. The cloned fragments of Y. pestis lpxM gene were then isolated following digestion with SacI and HindIII and electrophoresis in a 0.9 % agarose gel. After that, they were assembled within the pUC19 vector digested with SacI. The resulting recombinant plasmid, pUCLR, was used to transform E. coli JM83 by electroporation. This fragment, containing left and right shoulders of the lpxM gene with the polylinker XbaI-HindIII region from pBluescript SK (2) between them, was removed by digestion with SacI and recloned within the SacI site of the pCVD442 suicide vector. The resulting recombinant plasmid, pMSB8, was used to transform E. coli S17-1 lpir by electroporation. A 1264 bp BamHI fragment from pUC4K containing the Km R gene was inserted in the BcuI site at blunted ends in place of the deleted fragment of the lpxM gene (between the amplified shoulders of the lpxM gene). The resulting recombinant plasmid, pMSB3K, containing the indicated 59 and 39 flanking regions of the lpxM gene from Y. pestis 231 with a 0.59 kb deletion replaced by the Km R locus from pUC4K, was electroporated into E. coli S17-1 lpir.
The pMSB3K plasmid was introduced into Y. pestis strains by conjugation using polymyxin for counter-selection, the Km R Ap R exoconjugants were then counter-selected by growing on plates containing 5 % sucrose, and the Km R Ap S colonies in which allelic exchange had occurred were selected and deletion of the chromosomal lpxM gene confirmed by PCR (Donnenberg & Kaper, 1991) .
Isolation of LPS and SDS-PAGE. LPSs were extracted from dried cells with phenol/chloroform/light petroleum ether (Galanos et al., 1969) and purified by repeated ultracentrifugation (105 000 g, 4 h), following enzymic digestion of nucleic acids and proteins. The purity of the isolated LPS preparations was evident from the lack of protein and nucleic acid contaminants as determined by SDS-glycine PAGE with silver staining of the gels (Prior et al., 2001 ). The LPS preparations from the Y. pestis KM218 parental and KM218DlpxM mutant strains were designated LPS parent and LPS DlpxM , respectively. 
Virulence and vaccine efficacy of Y. pestis DlpxM
Mild acid degradation of LPS. Samples of LPS parent and LPS DlpxM were degraded with aqueous 2 % acetic acid at 100 uC for 4 h. The water-insoluble lipid precipitate (crude lipid A) from each sample was separated by centrifugation (12 000 g, 15 min), washed and resuspended in water, lyophilized and the solid preparation then treated with a chloroform/methanol mixture (1 : 1, v/v), which extracts contaminating phospholipids from lipid A. The water-soluble supernatant was fractionated by gel-permeation chromatography on a column (7062.6 cm) of Sephadex G-50 (S) (Amersham Biosciences) using aqueous 1 % aqueous acetic acid supplemented with 0.4 % pyridine as eluant. Monitoring was performed with a differential refractometer (Knauer). Fractions that contained core-like oligosaccharides were collected and lyophilized.
Mass spectrometry. High-resolution electrospray ionization Fourier transform ion cyclotron resonance (ESI FT-ICR) MS was performed in the negative ion mode using an Apex II instrument (Bruker Daltonics) equipped with a 7 T actively shielded magnet and an Apollo electrospray ion source as described previously (Knirel et al., 2005a) . Samples were dissolved at a concentration of~10 ng ml 21 in a 50 : 50 : 0.001 (by vol.) mixture of 2-propanol/water/triethylamine, and sprayed at a flow rate of 2 ml min
21
. Capillary entrance voltage was set to 3.8 kV, and dry gas temperature to 150 uC. The spectra were charge deconvoluted, and mass numbers given refer to the monoisotopic molecular masses.
Animals. Outbred Swiss Webster mice weighing approximately 20 g were used in animal experiments that were approved by the ethical committee of the State Research Center for Applied Microbiology and Biotechnology. Animals were kept in cages in groups of four to eight, and allowed to feed and drink ad libitum. Median lethal doses (LD 50 ), 50 % immunizing doses (ImD 50 ) and 95 % confidence intervals (CI) were measured according to the method of Kärber (Ashmarin & Vorob'ov, 1962) . (Parkhill et al., 2001) . DRecognition sites for restriction endonucleases are underlined, and the restriction endonucleases indicated. Immunization and challenge. Bacterial cultures of either the EV line NIIEG strain or the EVDlpxM mutant were grown for 48 h at 25 uC and administered subcutaneously in a total volume of 0.2 ml 0.9 % NaCl solution (with tenfold dilutions from 10 9 to 10 5 c.f.u.) as a single injection on day 0 (70 mice, divided into 10 groups of 7). Two groups of seven mice were treated only with 0.9 % NaCl solution. At day 21 post-immunization the mice were challenged subcutaneously with 3. 
RESULTS

Isolation and SDS-PAGE characterization of the LPSs
Each Y. pestis strain was grown at 25 u C and the corresponding LPS samples were isolated by phenol/chloroform/ light petroleum extraction and fractionated by SDS-PAGE. Examples of LPS migration for two pairs of isogenic strains are shown in Fig. 1 . LPS preparations from the DlpxM mutants migrated through the gel slightly faster and as more compact bands than those from the parent strains, suggesting that LPS molecules from the wild-type strains are, on average, larger.
Structural studies of the LPSs
LPS parent and LPS DlpxM from Y. pestis KM218 and KM260(11) were degraded under mild acid conditions to cleave the linkage between the core and lipid A. The isolated and purified lipid A and core oligosaccharide, as well as the whole LPS samples, were studied by ESI FT-ICR MS. The mass spectrum of the lipid A sample from Y. pestis KM218 LPS parent (Fig. 2a) showed the predominance of tetra-acyl and hexa-acyl variants, whose structures have been determined previously (Aussel et al., 2000; Knirel et al., 2005a) . LA hexa includes four primary 3-hydroxymyristoyl groups (3OH14 : 0) and two secondary acyl groups, one dodecanoyl (12 : 0) and one palmitoleoyl (16 : 1); tetra-acyl lipid A (LA tetra ) is devoid of both secondary fatty acids, and minor penta-acyl lipid A variants (LA1 penta and LA2 penta ) lack either of them (Fig. 2e) . Lipid A from Y. pestis KM218 LPS DlpxM was distinguished by the absence of LA hexa and LA1 penta , i.e. the structural variants that include the 12 : 0 group (Fig. 2b) . Instead, a significant increase in the content of LA2 penta with the single 16 : 1 secondary group was observed. Essentially the same structural variants were found when the mass spectra of the lipid A samples from Y. pestis KM260(11) LPS parent and LPS DlpxM were compared (Fig. 2c, d, respectively) .
No significant changes in the core composition and the content of the cationic sugar, 4-amino-4-deoxy-L-arabinose (Ara4N), were observed in LPS parent and LPS DlpxM from both strains studied (data not shown). Therefore, our data confirmed the finding of Rebeil et al. (2006) that Y. pestis DlpxM mutants are unable to incorporate the dodecanoyl group into lipid A and showed that the other LPS biosynthesis pathways are unaffected by the mutation.
Toxicity of LPSs in actinomycin D-sensitized mice
Several substances (Galanos et al., 1979; Seyberth et al., 1972) , including actinomycin D (Brown & Morrison, 1982; Seyberth et al., 1972) , when administered in sublethal amounts, have been documented to enhance by more than 1000-fold the sensitivity of mice to the lethal effect of LPS. Although the mechanisms of sensitization by these metabolic inhibitors have not been elucidated in detail, blocking of protein synthesis by inhibition of RNA synthesis may be involved. All animals challenged only with LPS-free actinomycin D solutions survived. All of the animal)], but with the overlapping 95 % CI the differences in LD 50 were not significant at P.0.05.
Affect of the deletion of lpxM on the lethality of virulent and attenuated Y. pestis strains in a murine system
The Y. pestis parental and DlpxM strains were used to assess the contribution to virulence made by having the genetic ability to synthesize a LA hexa . There was no effect on virulence of the Y. pestis wild-type strain 231 due to deletion of lpxM (Table 4 ).
When attenuated strains (i.e. lacking the pCD plasmid or with further mutations) of Y. pestis are injected into mice, the residual virulence can be evaluated with either the use of very high infective doses or immunocompromised animals treated with immunosuppressants (Anisimov, 2002a; Brygoo & Rajenison, 1973; Jackson & Burrows, 1956; Vasil'eva et al., 1988) . In experiments with attenuated strains, the use of both approaches indicated that DlpxM mutation resulted in a 2.5-16-fold reduction in virulence as measured by an increase in LD 50 (Table 4 ). The overlap in the 95 % CI for the LD 50 for wild-type, and lpxMdeleted strains EV and KM218 indicated the increase in LD 50 was not significant at P.0.05, but the one log increase in virulence for strain KIMD1 was significant at P,0.05. Thus loss of production of the hexa-acylated form of the LPS had a modest effect on virulence in these otherwise attenuated strains. ) of the vaccine strain EV were able to prevent death of 50 % of the immunized animals (Anisimov, 1999b) . Thus, the enhanced protective efficacy of the DlpxM mutant of the vaccine strain was only evident when a higher challenge inoculum of the virulent Y. pestis 231 was used.
DISCUSSION
Y. pestis easily overcomes the defence mechanisms of its animal hosts and readily proliferates in order to maintain the enzootic cycle essential to the organism's survival. To accomplish this, the organism must resist the innate immune response initiated by a variety of factors, including antimicrobial peptides and serum complement. The possibility to triumph over innate immunity response initiated by LPS-induced inflammatory cytokines is determined, in part, by the ability of the V antigen, which is a component of the type III secretion apparatus encoded on pCD, to provoke production of the anti-inflammatory cytokine, interleukin 10 (Brubaker, 2003) . Production of other components of the type III secretion system that interfere with innate immune cellular factors and are cytotoxic for host cells are also essential for high-level virulence of Y. pestis (Cornelis, 2000) . Resistance of Gram-negative bacteria to factors such as serum complement and antimicrobial peptides are generally related to carbohydrate components of the LPS, including both the monosaccharides present in the LPS oligosaccharide and 4-amino-Larabinose in the lipid A (Anisimov et al., 2005; Raetz & *The first and the last days of recorded deaths are given in parentheses.
Virulence and vaccine efficacy of Y. pestis DlpxM Whitfield, 2002) . The potency of LPS in regard to induction of inflammatory cytokines is determined by the overall composition and individual fatty acid constituents found in the lipid A (Kawahara et al., 2002; Rebeil et al., 2004; Raetz & Whitfield, 2002) . A balanced production of variant forms of LPS in a pathogen such as Y. pestis that is dependent on the site and state of infection, and influenced by environmental conditions such as temperature (Kawahara et al., 2002; Knirel et al., 2005a; Rebeil et al., 2004) , seems to have significant evolutionary value in the context of maintenance of the organism's natural life cycle. We have, therefore, set out to determine how the described chemical variations in the lipid A of the Y. pestis LPS contribute to virulence.
Y. pestis produces an overall less-acylated lipid A at 37 u C that elicits less intense inflammatory responses, which seems to be beneficial for the pathogen by preventing rapid host responses leading to quick elimination following infection (Kawahara et al., 2002) . At temperatures below 26 u C, the more potent hexa-acylated LPS form predominates. Although it has been postulated that this LPS isoform may be necessary for survival during infection of fleas, it was recently shown by Rebeil et al. (2006) that there is no difference in the ability of a wild-type or a DlpxM DlpxP Y. pestis double mutant to survive in the flea digestive tract or to produce a transmissible infection. Therefore, at the present time a specific role for production of the hexa-acylated isoform of the LPS in the flea vector is not defined.
To determine the role of fatty-acid substitution on Y. pestis virulence in mammals, we generated a DlpxM mutant of the highly virulent Y. pestis strain 231, which was unable to incorporate the dodecanoyl group into lipid A. Cultures of the parent and mutant strains grown at 25 u C prior to infection showed no significant differences in their LD 50 values. Thus, consistent with the findings of Rebeil et al. (2006) indicating there was no effect of LPS acylation on survival of Y. pestis in fleas, synthesis of the hexa-acylated LPS in arthropod vectors provided no advantage for Y. pestis during the initial stage of infection in the mammalian host. It remains to be determined if production of the hexa-acylated form of the LPS, which is increased at lower temperatures, is necessary for Y. pestis survival at the temperature of winter-hibernating rodents (6 u C).
In the case of attenuated Y. pestis strains, the DlpxM mutations resulted in a 2.5-16-fold reduction in residual virulence both in naïve and actinomycin D-sensitized animals. The same tenfold reduction in the toxicity of the LPS DlpxM preparation in actinomycin D-sensitized mice points towards the idea that, at least in the animals sensitized to LPS, the reduction of virulence of DlpxM mutants was due to a decrease of LPS DlpxM toxicity. This supposition was corroborated by the fact that the presence of a functional type III secretion system does not confer reliably increased virulence in actinomycin D-sensitized mice. In this assay the EV strain is only threefold more virulent than the KM218 strain, even though the latter is missing pCD.
While it does not appear that production of the hexaacylated form of LPS is needed for virulence of wild-type Y. pestis, DlpxM mutants of other Gram-negative pathogens, such as E. coli (Somerville et al., 1996) , Salmonella enterica serovar Typhimurium (Khan et al., 1998; Low et al., 1999; Sunshine et al., 1997) , Haemophilus influenzae (Lee et al., 1995; Nichols et al., 1997) , Shigella flexneri (D'Hauteville et al., 2002), Neisseria gonorrhoeae (Post et al., 2002) , N. meningitidis (van der Ley et al., 2001) and Yersinia pseudotuberculosis (Dentovskaya et al., 2006) , have reduced virulence. As these strains are less virulent than Y. pestis, it seems that in the absence of high levels of virulence, such as that which occurs in the plague bacillus, the lpxM gene does contribute to the organism's overall fitness to cause serious infections. Along the same lines, it was recently shown that even though the S. enterica serovar Typhimurium DlpxM mutant possesses less ability to induce production by dendritic cells of TNF-a, interleukin-1b and nitric oxide synthase than the parental strain (Kalupahana et al., 2003) , this effect was only seen at low multiplicities of infection (¡0.5). Infections at multiplicities of 5.0 or higher did not show any difference in the endotoxic properties of the two strains (Kalupahana et al., 2003) . Thus, the DlpxM mutants of highly virulent strains that can initiate clinical disease following inoculation with a low number of bacterial cells still can produce an endotoxic shock even when synthesizing a less toxic form of LPS, while DlpxM mutants of less virulent bacteria are more dependent on synthesizing a LPS with high endotoxic properties.
Two types of plague vaccines, live attenuated and killed whole-cell vaccines, are currently available for use in humans. Both vaccines cause generally mild reactions but sometimes reactions can be severe in a significant percentage of individuals immunized (Naumov et al., 1992; Perry & Fetherston, 1997) . The overwhelming majority of these reactions (Marshall et al., 1974; Meyer et al., 1974a, b; Naumov et al., 1992; Reisman, 1970) are thought to be due to the bacterial endotoxin (Dmitrovskii, 1994; Galanos & Freudenberg, 1993; Morrison & Rayn, 1987; Raetz & Whitfield, 2002; van Amersfoort et al., 2003; van der Poll & van Deventer, 1999) . Given that the Y. pestis LPS does not elicit protective immunity (Feodorova et al., 1999; Prior et al., 2001) it is reasonable to minimize endotoxic components in plague vaccine preparations. To this end, a number of LPS-free subunit and naked DNA candidate vaccines have been reported to be relatively nonreactogenic. These subunit and DNA vaccines incorporate the F1 capsular and the LcrV (or simply the V) antigens or their genes, and they can provide significant protection against experimental plague infections ). However, since F1 capsule-negative Y. pestis strains have been recovered from at least one case of human infection and there is serological diversity in the V antigen, the current subunit vaccines under evaluation may not be sufficiently comprehensive, particularly when considering that the Y. pestis strains found in North and South America are clonally derived from a single importation in the early 20th century, whereas in endemic plague foci in Russia and Asia there is considerably greater antigenic and genetic diversity (Anisimov et al., 2004) . While immunization with the live attenuated Y. pestis strain EV induces good protection against isolates with different antigenic compositions (Anisimov, 1999b) it is unlikely that one could generate viable LPS-free Y. pestis cells (Raetz & Whitfield, 2002; Rietschel et al., 1994) . However, by genetically manipulating the organism to only synthesize low-toxicity lipid A structures, it might be possible to produce a less reactogenic vaccine in an attenuated strain (van der Ley et al., 2001 ).
In the countries of the former Soviet Union, live-vaccinecontaining organisms grown at 28 u C that synthesize the hexa-acylated LPS are used for human immunization. This is due to the observation that Y. pestis cells grown at 28 u C are more viable and survive long-term storage better (Naumov et al., 1992) . However, growth at 28 u C decreases expression of the F1 antigen, although this did not apparently affect protection, as there were no differences observed in this parameter comparing individuals immunized with Y. pestis vaccine strain EV grown at 37 uC compared with that grown at 28 u C (Russell et al., 1995; Sheremet et al., 1987) . Importantly, if deleting the lpxM gene renders the vaccine strain less reactogenic and more immunogenic, as was shown here in the mouse studies, this might be useful for producing an improved live Y. pestis vaccine strain for human use, as long as the differences in specificity of human and mouse LPS receptors (Delude et al., 1995; Golenbock et al., 1991) do not impact the decreased reactogenicity of the DlpxM mutant of Y. pestis in humans. Any of the attenuated Y. pestis strains showing high protective potency, including Pgm 2 (Perry & Fetherston, 1997) , Ddam (Robinson et al., 2005) and Dpcm (Flashner et al., 2004) mutants, may be used for further DlpxM knockout. Nevertheless, further work is required to construct a DlpxM vaccine candidate strain lacking antibiotic resistance for future preclinical trials.
